Consolidated Financial Statements

Bayer Group Consolidated Income Statements

 

 

Note

 

2015

 

2016

 

 

 

 

€ million

 

€ million

2015 figures restated

1

For definition see Combined Management Report, Chapter “Alternative Performance Measures Used by the Bayer Group.”

Net sales

 

[7]

 

46,085

 

46,769

Cost of goods sold

 

 

 

(21,040)

 

(20,295)

Gross profit

 

 

 

25,045

 

26,474

Selling expenses

 

[8]

 

(12,272)

 

(12,474)

Research and development expenses

 

[9]

 

(4,274)

 

(4,666)

General administration expenses

 

 

 

(2,092)

 

(2,256)

Other operating income

 

[10]

 

1,109

 

898

Other operating expenses

 

[11]

 

(1,275)

 

(934)

EBIT1

 

 

 

6,241

 

7,042

Equity-method loss

 

[13]

 

(9)

 

(26)

Financial income

 

 

 

371

 

151

Financial expenses

 

 

 

(1,367)

 

(1,280)

Financial result

 

[13]

 

(1,005)

 

(1,155)

Income before income taxes

 

 

 

5,236

 

5,887

Income taxes

 

[14]

 

(1,223)

 

(1,329)

Income from continuing operations after income taxes

 

 

 

4,013

 

4,558

Income from discontinued operations after income taxes

 

[6]

 

85

 

268

Income after income taxes

 

 

 

4,098

 

4,826

of which attributable to noncontrolling interest

 

[15]

 

(12)

 

295

of which attributable to Bayer AG stockholders (net income)

 

 

 

4,110

 

4,531

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share

 

[16]

 

 

 

 

From continuing operations

 

[16]

 

 

 

 

Basic

 

 

 

4.87

 

5.12

Diluted

 

 

 

4.87

 

5.12

From discontinued operations

 

[16]

 

 

 

 

Basic

 

 

 

0.10

 

0.32

Diluted

 

 

 

0.10

 

0.32

From continuing and discontinued operations

 

[16]

 

 

 

 

Basic

 

 

 

4.97

 

5.44

Diluted

 

 

 

4.97

 

5.44